CBD isn’t a miracle cure for everything that ails a person – but science shows that it has the potential to help treat a number of health conditions.
Academic rigour, journalistic flair
Articles on Cannabidiol
Displaying 1 - 20 of 22 articles
With the dual threats of antibiotic resistance and emerging pandemics, finding new drugs becomes even more urgent. A trove of medicines may be lying under our nose.
Scholars weigh in on the known and unknown about marijuana and its incarnations.
Some psychedelic drugs – paired with therapy – hold great potential for helping sufferers of PTSD, depression and other mental health disorders.
Non-intoxicating cannabis products are safe and well tolerated by those who use them, so why not lower the clinical threshold for their manufacture and sale?
We can make the case against using medicinal cannabis to manage chronic pain by debunking three myths.
Pediatricians say they are getting increasing requests from parents for medical cannabis for kids for a growing list of conditions.
CBD may not be a panacea for your aches and pains – and it certainly isn’t for COVID-19.
There is no evidence yet that cannabidiol (CBD) is effective in treating heroin addiction, despite news headlines claiming this.
A study suggests that CBD could help treat people with opioid addiction. But before you go buy a bottle for any use, it’s important to know that it has been FDA-approved to treat only one disease.
As marijuana and its derivatives are sold legally in more states, pets are getting into pot, accidentally. And some owners are intentionally giving them CBD. A vet explains the dangers.
Marijuana is known for delivering a good high. But the plant’s uses go well beyond the recreational. Marijuana contains a trove of medicinal compounds whose uses we are just now discovering.
Cannabidiol, or CBD, is being touted in popular culture as a miracle cure-all. From creams to gummies and more, CBD has exploded onto the health scene. But what does the science actually say?
A drug made from a molecule produced from cannabis gained approval from the FDA on June 25. But the molecule, CBD, is decidedly different from some other ingredients in cannabis: It doesn’t result in a high.
The Home Office has announced a review of the law around medical cannabis in Britain – so what does the law say?
A drug made from a molecule produced from cannabis gained unanimous approval from an FDA panel. But the molecule, CBD, is decidedly different from some other ingredients in cannabis: It doesn’t result in a high.
Cannabidiol shows promise in treating psychosis in a placebo controlled trial.
NSW is about to embark on the largest and most definitive clinical trial ever of medicinal cannabis for chemotherapy-induced nausea and vomiting.
The Australian government will now accept licence applications for groups wanting to grow cannabis for scientific and medical purposes. But there’s still a lot we don’t know about this complex plant.
With restrictions to cannabis loosening at the state level, research is badly needed to get the facts in order.
Job Board
-
Union Organiser
-
Student Services Representative, Contact Centre
-
Centre of Excellence Chief Operating Officer, Quantum Biotechnology (QUBIC)
-
Director, Monash University Museum of Art (MUMA)
-
Data and Multimedia journalist
Top contributors
-
Professor of Pharmacy Practice, University of Connecticut
-
Professor of Pharmacy Practice, Drake University
-
Professor and Chair of Pharmacodynamics, University of Florida
-
Assistant Professor of Pharmacodynamics, University of Florida
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Director, Southern Cross Plant Science, Southern Cross University
-
Reader in Crimimology and Social Policy, University of Birmingham
-
Assistant Professor of Psychology, West Virginia University
-
Post-doctoral researcher, UCL
-
Research Associate, University of Connecticut
-
Medical oncologist from Chris O`Brien Lifehouse cancer hospital, Lead researcher NSW Government clinical trial into the role of cannabis-derived medicines in chemotherapy-induced nausea and vomiting, Clinical Associate Professor., University of Sydney
-
Principal Communications and Events Officer Centre for Medicinal Cannabis Research and Innovation Office of the NSW Chief Scientist & Engineer, Office of the Chief Scientist
-
Research Assistant Professor, University of Michigan
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
